首页|Halcyon加速器在乳腺癌保乳术后放射治疗中的临床应用

Halcyon加速器在乳腺癌保乳术后放射治疗中的临床应用

扫码查看
目的 探究在Halcyon直线加速器上使用调强适形放射治疗(IMRT)和容积旋转调强放射治疗(VMAT)进行乳腺癌保乳术后放射治疗的临床应用。方法 选择乳腺癌保乳术后放射治疗患者25例,年龄36~61岁,平均年龄50。9岁;左侧乳腺癌15例,右侧乳腺癌10例;肿瘤分期均为T1~T2、N0、M0。计划设计均在Eclipse计划系统上,每例患者分别采用IMRT和VMAT进行计划设计。对两类计划的主要剂量学参数、剂量分布、γ通过率和照射时间进行比较。结果 所有计划均可临床使用,两组计划靶区D95%、平均剂量Dmean差异较小(P>0。05),靶区均匀性指数(HI)(IMRT组0。06±0。01 vs VMAT 组 0。06±0。01),差异无统计学意义(P>0。05),适形性指数(CI)(1MRT 组 0。85±0。03 vs VMAT 组 0。92±0。02),差异有统计学意义(P<0。05)。IMRT组患侧肺V5、V20和平均剂量,心脏平均剂量,健侧肺V5均低于VMAT组,差异具有统计学意义[患侧肺 V5(41。36±2。04)%vs(47。58±2。42)%、患侧肺 V20(15。04±2。90)%vs(16。35±1。97)%、患侧肺平均剂量(886。32±79。41)cGy vs(993。49±50。14)cGy、心脏平均剂量(209。23±98。12)cGy vs(277。60±83。18)cGy、健侧肺 V5(2。10±1。35)%vs(14。06±8。62)%。P<0。05]。VMAT 组 γ 通过率优于 IMRT 组,差异有统计学意义[3 mm/3%(99。72±0。20)%vs(99。38±0。37)%;2 mm/2%(97。22±1。05)%vs(96。99±0。91)%。P<0。05]。IMRT 组照射时间(2。08±0。27)min,VMAT组照射时间(0。87±0。04)min,VMAT组节省超过55%照射时间,差异有统计学意义(P<0。05)。结论 使用Halcyon直线加速器进行保乳术后放射治疗,IMRT计划和VMAT计划均能满足临床治疗需求,采用VMAT技术会提高靶区的剂量分布,明显提高计划执行效率。
Clinical application of radiotherapy for breast cancer after breast-conserving surgery on Halcyon accelerator
Objective To explore the clinical application of intensity modulated radiation therapy(IMRT)and volumetric mod ulated arc therapy(VMAT)on Halcyon linear accelerator for radiotherapy after breast-conserving surgery in patients with breast cancer.Methods A total of 25 female patients with breast cancer performed radiotherapy after breast-conserving surgery were enrolled,which aged 36-61 years old with mean age of 50.9 years old;15 cases of left breast cancer and 10 of right breast cancer;the tumor stages were T1-T2,NO and MO.The plans were designed on Eclipse planning system,the IMRT and VMAT were both used in each patient.The main dosimetric parameters,dose distribution,γ pass rate and irradi-ation time of 2 plans were compared.Results All plans were available for clinical,there was no significant difference in D95%and mean dose Dmean between 2 groups(P>0.05).The target homogeneity index(HI)of 2 groups(IMRT group 0.06±0.01 vs VMAT group 0.06±0.01)(P>0.05)were barely the same.In addition,the difference conformity index(CI)of IMRT group(0.85±0.03)was statistically significantly lower than VMAT group(0.92±0.02)(P<0.05).The V5,V20 and Dmean of affected lung,heart Dmean,and healthy lung V5 in IMRT group were statistically significantly lower than those in VMAT group[affected lung V5(41.36±2.04)%vs(47.58±2.42)%,affected lung V20(15.04±2.90)%vs(16.35±1.97)%,affected lung Dmean(886.32±79.41)cGy vs(993.49±50.14)cGy,heart Dmean(209.23±98.12)cGy vs(277.60±83.18)cGy,healthy lung V5(2.10±1.35)%vs(14.06±8.62)%.P<0.05].The γ pass rate of VMAT group was better than that of IMRT group,and the difference was statistically significant[3 mm/3%(99.72±0.20)%vs(99.38±0.37)%;2 mm/2%(97.22±1.05)%vs(96.99±0.91)%.P<0.05].The irradiation time of IMRT group was(2.08±0.27)minutes,and irradiation time of VMAT group was(0.87±0.04)minutes,the VMAT group saved more than 55%of irradiation time,and the difference was statistically significant(P<0.05).Conclusion It is demonstrat-ed that both IMRT plan and VMAT plan could meet the clinical requirements when Halcyon linear accelerator is used for radiotherapy after breast-conserving surgery,and VMAT technology could improve dose distribution of target area and sig-nificantly improve efficiency of plan execution.

eclipseHalcyonradiotherapy after breast-conserving surgeryintensity modulated radiation therapydose distributionsirradiation time

尹楚欧、邓娟、梅国建、刘江

展开 >

德阳市人民医院肿瘤科,四川德阳 618000

Eclipse Halcyon 保乳术后放射治疗 调强放射治疗 剂量分布 照射时间

成都中医药大学"杏林学者"医院专项课题

XJ2023000101

2024

生物医学工程与临床
天津市生物医学工程学会,天津市第三中心医院

生物医学工程与临床

CSTPCD
影响因子:0.462
ISSN:1009-7090
年,卷(期):2024.28(5)